Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 948046 FRANKFURT AM MAIN, 2M
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$8,870,412
-$11,321,688 QoQ
Shares Held
482,875
-53.2% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 215 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 29% Shared 0% None 71%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. VRDN ranks #48 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in VRDN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,870,412 482,875
2026-03-31 $20,192,100 1,032,316
2025-12-31 $14,930,068 479,758
2025-09-30 $20,230,536 937,467
2025-06-30 $5,409,392 386,938
2025-03-31 $5,348,970 396,808
2024-12-31 $7,723,093 402,874
2024-09-30 $8,634,693 379,547
2024-06-30 $630,268 48,445
2024-03-31 $818,994 46,773
2023-12-31 $931,987 42,791
2023-09-30 $337,831 22,023
2023-06-30 $2,204,237 92,654
2023-03-31 $6,464,659 254,114
2022-12-31 $499,082 17,086
2022-09-30 $227,270 11,081
2022-06-30 $147,725 12,768